Chester M. Davis
- Psychiatry and Mental health top 5%
- Spectroscopy top 10%
- Pharmacology top 10%
- Pharmacology top 5%
- Analytical Chemistry top 5%
- Co-authors
- David C. FenimoreMichael W. JannStephen R. SakladLarry EreshefskyNeil BurchCharles A. HarringtonJeffrey L. BrowningAnn L. Richards
- Topics
- Analytical Chemistry and Chromatography (4 papers)Schizophrenia research and treatment (4 papers)Electroconvulsive Therapy Studies (2 papers)
- Partner nations
- United StatesPolandTaiwan
In The Last Decade
Chester M. Davis
17 papers receiving 654 citations
Peers
Comparison fields: 5 of 109
- Psychiatry and Mental health 261
- Spectroscopy 131
- Pharmacology 118
- Pharmacology 103
- Analytical Chemistry 100
Countries citing papers authored by Chester M. Davis
This map shows the geographic impact of Chester M. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chester M. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chester M. Davis more than expected).
Fields of papers citing papers by Chester M. Davis
This network shows the impact of papers produced by Chester M. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chester M. Davis. The network helps show where Chester M. Davis may publish in the future.
Co-authorship network of co-authors of Chester M. Davis
This figure shows the co-authorship network connecting the top 25 collaborators of Chester M. Davis. A scholar is included among the top collaborators of Chester M. Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chester M. Davis. Chester M. Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 23 | |
| 2 | 40 | |
| 3 | 46 | |
| 4 | 15 | |
| 5 | 15 | |
| 6 | 22 | |
| 7 | 91 | |
| 8 | 97 | |
| 9 | 57 | |
| 10 | 5 | |
| 11 | Haloperidol and reduced haloperidol plasma levels in selected schizophrenic patients. | 69 |
| 12 | 7 | |
| 13 | 145 | |
| 14 | 5 | |
| 15 | 18 | |
| 16 | 3 | |
| 17 | 77 |
About Chester M. Davis
Chester M. Davis is a scholar working on Biological Psychiatry, Psychiatry and Mental health and Behavioral Neuroscience, having authored 17 papers that have together received 735 indexed citations. Recurring topics across this work include Analytical Chemistry and Chromatography (4 papers), Schizophrenia research and treatment (4 papers) and Electroconvulsive Therapy Studies (2 papers). The work is most often cited by research in Biological Psychiatry (55 citations), Psychiatry and Mental health (261 citations) and Pharmacology (103 citations). Chester M. Davis has collaborated with scholars based in United States, Poland and Taiwan. Frequent co-authors include David C. Fenimore, Michael W. Jann, Stephen R. Saklad, Larry Ereshefsky, Neil Burch, Charles A. Harrington, Jeffrey L. Browning, Ann L. Richards, Charles L. Bowden and Mark D. Watanabe. Their work appears in journals such as Analytical Chemistry, Analytical Biochemistry and Biological Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.